Phenotype-Based Targeted Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes
Diabetologia 2024 May 01;67(5)822-836, P Cardoso, KG Young, ATN Nair, R Hopkins, AP McGovern, E Haider, P Karunaratne, L Donnelly, BA Mateen, N Sattar, RR Holman, J Bowden, AT Hattersley, ER Pearson, AG Jones, BM Shields, TJ McKinley, JM DennisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.